-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Good news came again from the centralized recruitment and procurement of medicines
Previously, the centralized procurement of national medicines did not involve proprietary Chinese medicines, because many proprietary Chinese medicines are exclusively produced, their formulas are kept secret, and there is a lack of competition from similar products, so companies have the confidence not to bid prices
Nevertheless, there is still a lot of room for operation in the centralized procurement of proprietary Chinese medicines
The price rise of Chinese patent medicines is a phenomenon that has lasted for many years
The particularity of Chinese patent medicine has also been fully reflected in the policy
In addition, disordered competition of Chinese patent medicines is common at present, and medicinal materials are shoddy and of varying quality, which has become a difficult problem affecting the development of traditional Chinese medicine
It can be seen that the particularity and industrial characteristics of Chinese patent medicines are destined to carry the greater expectations of the society in the centralized procurement of Chinese patent medicines